The expression of SMO was also increased in the BM of MDS patients, moreover, the patients with a higher expression of SMO showed significantly shorter 5-year EFS and 5-year AML evolution than those with a lower expression of SMO. Here, SMO is linked to myelodysplastic syndrome.